Nucleic Acid Production Service
GMP-grade plasmid and mRNA manufacturing, from strain construction to clinical supply. Customized solutions accelerate timelines and reduce costs.
Key advantages:
-
High standards: Plasmid quality meets DNA vaccine-level specifications.
-
Compliance: Clear and traceable strain sources, manufactured under GMP conditions.
-
High yield: Up to 10 L bioreactor capacity, delivering more than 500 mg plasmid per batch.
-
Efficiency: Plasmid supply timelines shortened to less than one month.
Nucleic Acid, including plasmids and mRNA, are essential starting materials for the cell therapy, gene therapy, and vaccine industries.
Our nucleic acid production platform is dedicated to delivering high-quality plasmid products at different grades, offering both customized production and a diverse selection of off-the-shelf products. This approach significantly reduces production time and cost, effectively accelerating project progress.
The platform provides end-to-end, integrated services, covering plasmid stain construction, clone screening, seed bank establishment, process development, non-clinical grade plasmid manufacturing, and GMP-grade plasmid production for clinical use.
Get in Touch
We’re here to answer your questions and explore potential collaborations.